767 — Zhong Ji Longevity Science Balance Sheet
0.000.00%
- HK$278.73m
- HK$288.03m
- HK$166.18m
- 12
- 39
- 48
- 20
Annual balance sheet for Zhong Ji Longevity Science, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 40.8 | 19.4 | 60.1 | 81.1 | 47.8 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 42.9 | 80 | 61.7 | 206 | 429 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 178 | 277 | 310 | 323 | 494 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.53 | 6.48 | 2.78 | 11.8 | 7.31 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 478 | 517 | 485 | 509 | 526 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 21.8 | 44.5 | 63.4 | 73.3 | 122 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Liabilities | 49.4 | 73.7 | 91 | 106 | 152 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 429 | 444 | 394 | 403 | 373 |
| Total Liabilities & Shareholders' Equity | 478 | 517 | 485 | 509 | 526 |
| Total Common Shares Outstanding |